CD07223 1.5% Topical Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD07223 1.5% Topical Gel, covering 2014-08-12 to 2014-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo [Phase 2, Phase 3]